Kiernan Jane E
- SEC CIK
- 0001379171
No open-market purchases or sales filed in the past year.
Current role at each company
- TMCI Treace Medical Concepts, Inc.Directoras of May 19, 2026
- AXNX Axonics, Inc.Directoras of Nov 15, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Kiernan Jane E as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
TMCI Treace Medical Concepts, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 14, 2024 (view filing) | May 14 | Same day | Kiernan Jane EDirector | PPurchase | +19.4K | $5.17 | +$100.1K | +346.6%24.9K after |
AXNX Axonics, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 7, 2022 (view filing) | Apr 1-Jul 5 | 97 daysLate | Kiernan Jane EDirector | SSale | −7.00K | $60.68 | −$424.7K | −32.2%14.8K after | 2 lots |
| Mar 31, 2022 (view filing) | Mar 29 | 2 days | Kiernan Jane EDirector | SSale | −5.25K | $60.50 | −$317.6K | −40.9%7.59K after | 2 lots |